CollimateHealth

Coherence

This company develops minimally invasive implants and neurotechnology to monitor and manage cancer via real-time electrical signaling for patients with aggressive tumours.

Synaptiq

This company develops artificial intelligence software for medical imaging to assist radiotherapy clinics with tumor and organ delineation for cancer treatment planning.

Bactheravax

This company develops therapeutic vaccines targeting tumour-associated bacteria to improve treatment sensitivity and immune responses for patients with colorectal and other cancers.

GT Medical Technologies

This company produces bioresorbable radiotherapy implants for patients with operable brain tumors to deliver targeted radiation immediately following surgical removal.

Alpha-9 Theranostics

This clinical-stage biotechnology company develops targeted radiopharmaceuticals to treat cancer patients by delivering radiation directly to tumours while sparing healthy tissue.

HEPTA Medical

This company develops a microwave ablation platform with integrated temperature sensors for clinicians to treat early-stage lung cancer patients using minimally invasive procedures.

Cold Start Therapeutics

This company develops multimeric fusion proteins using machine learning to target cancer cells and engage immune cells for patients with oncological diseases.

Neobe

The company develops engineered microbial biotherapeutics designed to disrupt the microenvironment of solid tumours for cancer patients receiving immunotherapy.